that deals, at least in part, with prescribing of stimulants such as Adderall and
Vyvanse; and (2) professional ethics. The following terms apply:

(a) it is the Respondent’s responsibility to locate, enroll in and obtain the Panel’s
approval of the courses before the courses are begun;

(b) the Respondent must provide documentation to the Panel that the Respondent
has successfully completed the courses;

(c) the courses may not be used to fulfill the continuing medical education credits
required for license renewal; and

(d) the Respondent is responsible for the cost of the courses; and

(4) the Respondent shall be subject to supervision for a minimum of TWO (2) YEARS
(eight quarterly reports) by a disciplinary panel approved supervisor who is board
certified. The following terms apply to the supervision:

(a) the panel will provide the supervisor with a copy of the Consent Order dated
November 30, 2022 and of this Order Terminating Suspension and Imposing
Probation and any other documents the Panel deems relevant;

(b) the Respondent shall grant the supervisor access to patient records selected by
the supervisor, which shall, to the extent practicable, focus on the type of
treatment at issue in the Respondent’s charges;

(c) if the supervisor for any reason ceases to provide supervision, the Respondent
shall immediately notify the Board and shall not practice medicine beyond the
30th day after the supervisor has ceased to provide supervision and until the
Respondent has submitted the name and professional background, and written
notice of confirmation, from a proposed replacement supervisor to the
disciplinary panel;

(d) it shall be the Respondent’s responsibility to ensure that the supervisor:

(i) reviews the records of ten (10) patients each month, such patient records to
be chosen by the supervisor and not the Respondent;

(ii) meets in person with the Respondent at least once each month and discuss
in-person with the Respondent the care the Respondent has provided for
these specific patients;

(ili) be available to the Respondent for consultations on any patient;

(iv) maintain the confidentiality of all medical records and patient information

(v) provides the Board with quarterly reports which detail the quality of the
Respondent’s practice, any deficiencies, concerns or needed improvements,
as well as any measures that have been taken to improve patient care;

(vi) immediately report to the Board any indication that the Respondent may
pose a substantial risk to patients;

 

 
